Ampio Pharmaceuticals (AMPE) Shares Gap Up to $1.36
Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE)’s share price gapped up prior to trading on Monday . The stock had previously closed at $1.25, but opened at $1.36. Ampio Pharmaceuticals shares last traded at $1.65, with a volume of 2154900 shares traded.
Separately, ValuEngine upgraded Ampio Pharmaceuticals from a “strong sell” rating to a “sell” rating in a report on Wednesday, October 11th.
Ampio Pharmaceuticals Company Profile
Ampio Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.
Receive News & Ratings for Ampio Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.